Recommended Magnesium Dosing in the ICU
For ICU patients with hypomagnesemia, administer 1-2 g of magnesium sulfate IV for mild-to-moderate deficiency (serum Mg <1.3 mEq/L or 1.7 mg/dL), with the specific dose and rate depending on clinical urgency and severity.
Clinical Context-Specific Dosing
Emergency/Life-Threatening Situations
Cardiac arrest with hypomagnesemia or torsades de pointes: 1-2 g MgSO₄ IV push 1
- This is a Class I recommendation for cardiotoxicity and polymorphic ventricular tachycardia
- Administer as rapid bolus in arrest situations
Polymorphic VT with QT prolongation (torsades): 1-2 g IV over 15 minutes 2
- Follow with maintenance infusion of 1-4 mg/min if arrhythmia persists
Non-Emergency Hypomagnesemia Replacement
Initial bolus approach:
- Start with 1-2 g MgSO₄ IV for mild-to-moderate hypomagnesemia (Mg 1.0-1.9 mEq/L)
- Expect serum increase of approximately 0.15 mg/dL per 1 g administered 3
- Recheck magnesium level within 24 hours
Infusion rate considerations: The evidence shows no benefit to prolonged infusion rates in non-emergency settings. A 2020 study comparing prolonged (0.5 g/h) versus short infusion rates (>0.5 g/h) found no difference in magnesium replacement requirements, days requiring repletion, or achievement of therapeutic levels 4. Therefore, infusion rates of 1-2 g/h are appropriate for non-emergency replacement, avoiding unnecessarily prolonged infusions.
Continuous infusion protocol (for sustained elevation):
- 10 mmol bolus followed by 1.5-3 mmol/h continuous infusion achieves stable serum levels of 1.64-1.77 mmol/L within 7-25 hours 5
Predictors of Greater Response
Target higher initial doses when these factors are present:
- Lower baseline magnesium (most important predictor) 3
- Reduced renal function (associated with greater serum increase) 3
- Severe hypomagnesemia shows median increase of 0.25 mg/dL per gram versus 0.22 mg/dL for mild-to-moderate 3
Critical Monitoring Points
Check magnesium levels:
- Within 24 hours after replacement 6, 3
- After 6-7 days in ICU for at-risk patients 7
- More frequently in patients on CRRT (90% develop deficiencies within 5-7 days) 7
Important caveat: Standard replacement achieves target levels (≥2 mEq/L) in only 59.8% of episodes versus the expected 100% based on traditional "rules of thumb" 6. This means you will frequently need to redose.
Route Selection: IV vs Enteral
While a 2026 trial found enteral magnesium did not establish noninferiority to IV replacement (mean difference -0.12 mmol/L at 24 hours), enteral administration substantially reduced costs, waste, and IV fluid requirements 8. However, for ICU patients requiring reliable and rapid correction, IV remains the preferred route, particularly given:
- Unpredictable absorption in critically ill patients
- Need for rapid correction in most ICU scenarios
- Enteral route reduced urinary magnesium loss but achieved lower serum levels
Common Pitfalls to Avoid
Undertreating based on "rules of thumb": The traditional estimate that 1 g raises Mg by 0.15 mEq/L significantly overestimates actual response 6
Not checking follow-up levels: In one study, follow-up magnesium was only checked in 58.6% of replacement episodes 6
Missing concurrent deficiencies: Always correct serum magnesium levels before treating hypokalemia, as inadequate intracellular magnesium causes PTH resistance and impairs potassium homeostasis 9
Ignoring renal losses: Patients on diuretics, with diarrhea, or on CRRT require more aggressive monitoring and often higher/more frequent dosing 1, 7
Overlooking ionized magnesium: Recent data suggests ionized magnesium (iMg) may be more sensitive for detecting arrhythmia risk than total magnesium, though total magnesium correlates better with length of stay 10